Youth will rise to the fore at today's European Congress of Radiology. At just 51 years of age, Prof. Christian Herold is one of the youngest ECR presidents and the first from Austria. He admits that he represents the new generation of leaders.
Youth will rise to the fore at today's European Congress of Radiology. At just 51 years of age, Prof. Christian Herold is one of the youngest ECR presidents and the first from Austria. He admits that he represents the new generation of leaders.
"In industry, 35 to 40 years would be the right age to be the CEO of a large company, so why should radiology be different?" he said. "Finding the time to run a meeting like this is not easy, but I'm not intimidated by a big workload, and it's essential to find some balance in your life between work, sports, lifestyle, and family. It's also important to remember there's only so much you can do in a 48-hour day!"
Herold is director of the department of diagnostic radiology at the Medical University of Vienna and its university hospital, Allgemeines Krankenhaus. He is also a part-time faculty member in the radiology department at Johns Hopkins Medical Institutions.
Herold is sure that ECR delegates will appreciate the quality of this year's scientific program. He singles out the new categorical course on multislice CT for special mention. Eight separate sessions will focus on implementation, heart, chest, bowel/colon/rectum, abdomen, bones/joints, brain and head and neck, and angiography.
Minicourses on women's imaging and molecular imaging are also likely to prove popular. Three 90-minute sessions on these two subjects will be held on the first three mornings of the congress.
Austria, the Czech Republic, and China will be the host countries at this year's congress.
"We wanted to recognize that China has become such an important partner with ECR, with an increasing number of presentations and attendees coming from there," he said.
At ECR 2007, the largest number of accepted abstracts was submitted by researchers in Italy (278). Other countries followed:
The rejection rate was 61.6% for scientific papers and for scientific and educational exhibits. Of the accepted abstracts, 153 are in neuroimaging, 147 in abdominal viscera, 147 in cardiac, 142 in intervention, 141 in musculoskeletal, 120 in genitourinary, 118 in chest, 115 in breast, 109 in vascular, 108 in GI tract, and 88 in head and neck.
Special sessions from the European Society of Radiology will focus on the management of change, the European Directive on MR Safety, biomedical imaging research, cancer therapy and follow-up, and coping with new challenges in radiology. In the April edition of DI Europe, a wide-ranging article with ESR president, Prof. Nicholas Gourtsoyiannis, will discuss the society's current and future activities.
The ECR Today newspaper will make a comeback at this year's congress. Copies will be published on Friday, Saturday, Sunday, and Monday/Tuesday. DI Europe's editors will contribute articles.
For more online information, visit Diagnostic Imaging's ECR 2007 Webcast.
ECR's drive for perfection has downside
New MR regulations spur industry backlash, lobbying effort
Researchers confront strengths, limitation of 64-slice CTA
FDA Grants Expanded 510(k) Clearance for Xenoview 3T MRI Chest Coil in GE HealthCare MRI Platforms
November 21st 2024Utilized in conjunction with hyperpolarized Xenon-129 for the assessment of lung ventilation, the chest coil can now be employed in the Signa Premier and Discovery MR750 3T MRI systems.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
Ultrasound Device Garners FDA De Novo Nod for Kidney Stone Clearance
November 14th 2024Emerging research demonstrated that the Stone Clear device, which facilitates post-lithotripsy clearance of kidney stone fragments, led to a 70 percent lower risk of relapse in comparison to observation in a control group.